Home
Transdermal and Microneedle Drug Delivery
11 November - 12 November 2024
Transdermal and Microneedle Drug Delivery

Join SAE’s 3rd annual Transdermal and Microneedle Drug Delivery conference – leading the transition of drug delivery beyond the needle.
 

Collaborate across a high-level 2-day programme.


Collaborate with forward-thinking drug development and delivery experts to discuss case studies and real-world examples of delivery R&D, vaccine application, and diversifying capabilities.


 

Transdermal and Microneedle Array Patches (MAPs) are one of the exciting fields and fast-growing in pharmaceutical development. Offering a combination of unrivalled potency – from increased community access, to consistent long-term delivery and diagnostic capabilities – this technology is at the vanguard of increasing efficacy and global access to transformative products.
 

Highlights include:

  • Successes in clinical data and vaccine delivery 
  • Innovative capabilities and applications of transdermal and microneedle patches
  • Manufacturing challenges and progress
  • Insights and Q&A opportunities with key regulators

FEATURED SPEAKERS

Aleksandra Puton

Aleksandra Puton

Business Manager, Biotts
Dr Mahmoud Ameri

Dr Mahmoud Ameri

VP, Emergex USA Corporation
Dr Muhammet Avcil

Dr Muhammet Avcil

Managing Director, Imperial BioScience
Dr Niraj Vasisht

Dr Niraj Vasisht

Chief Technology Officer, Corium International
Dr Pawel Biernat

Dr Pawel Biernat

Chief Technology Officer and Co-Founder, Biotts
Dr Sanjiv Sharma

Dr Sanjiv Sharma

Senior Lecturer in Medical Engineering, Swansea University
Steven Damon

Steven Damon

CEO, Micron Biomedical

Aleksandra Puton

Business Manager, Biotts
Aleksandra Puton

Associated with the business for over 10 years, she has competence in project management, marketing and communication supported by many years of cooperation with customers in the pharmaceutical industry. Responsible for marketing and customer acquisition for the unique MTC-Y technology. Graduate of the University of Warsaw.

Clemens Gunther

Former Senior Expert Nonclinical Safety, Bayer AG
Clemens Gunther

Dr. Clemens Günther received his diploma in biology and doctorate for natural sciences from the Free University, Berlin-Germany.
 

Dr. Clemens Günther started his professional career in 1990 at Schering AG, Berlin-Germany. From 2007 to 2013, he was Director and Head of Global Preclinical Development at Intendis GmbH, branded later-on as Bayer Dermatology. In this position, he was responsible for Nonclinical Safety for the marketed product portfolio of Bayer Dermatology as well as the global preclinical development strategy including human DMPK for development and life cycle management projects.
After integration of Intendis into Bayer in 2013, he became Director Nonclinical Safety Consumer Care and later-on Senior Expert Nonclinical Safety within the Division of Bayer Pharmaceuticals. He held this position until June 2024.
 

Dr. Clemens Günther gained about 35 years experience in drug development. He has been involved in nonclinical development and regulatory toxicology of small molecules, biologics, medical devices and drug device combination products including Transdermal Therapeutic Systems. His expertise includes also the Toxicological Risk Assessment of impurities as well as extractables and leachables.
 

David Hoey

Chief Executive Officer, Vaxxas
David Hoey

Dr Mahmoud Ameri

VP, Emergex USA Corporation
Dr Mahmoud Ameri

Dr. Mahmoud Ameri currently VP at Emergex USA, spearheads microneedle research and operational initiatives at the Fremont site in California. He brings over two decades of expertise in drug delivery, preclinical and clinical development of combination products. A co-founder of Zosano Pharma he played a crucial role in the development of the microneedle technology. Prior to that he was a key innovator at Alza/J&J co-inventing the microneedle transdermal system. Dr. Ameri earned his PhD from the University of Manchester, School of Pharmacy in the United Kingdom.

Dr Muhammet Avcil

Managing Director, Imperial BioScience
Dr Muhammet Avcil

Dr Muhammet Avcil gained his honours degree in Chemistry and an MSc in Molecular Synthesis (Organic Syntheses) from the University of Sussex. After his MSc, He worked as a Research Assistant at the University of Sussex. He conducted his PhD research at the University of Sussex and Imperial College London. He has over 19 years of experience in biotechnology, drug discovery and development, working at universities and senior management positions in various institutions. He is a key figure in the management and strategic development of Imperial Bioscience and continues to get involved in the research and development of the company.
 

Dr Niraj Vasisht

Chief Technology Officer, Corium International
Dr Niraj Vasisht

Dr Pawel Biernat

Chief Technology Officer and Co-Founder, Biotts
Dr Pawel Biernat

Co-founder and patent co-author at Biotts, with a PhD in Pharmacy from the Medical University of Wroclaw. A seasoned pharmaceutical technologist with over two decades of experience, specializing in the design of drug active ingredient nanocarriers, transdermal systems, and sterile, non-oral drug formulations. Renowned for contributions to numerous domestic and international scientific publications. At Biotts, excels in creating proprietary formulations and patents for innovative solutions.

Dr Sanjiv Sharma

Senior Lecturer in Medical Engineering, Swansea University
Dr Sanjiv Sharma

Dr Sanjiv Sharma received his PhD on the development of analytical methods for determination of certain pharmaceuticals and their metabolites using miniaturised separation system in 2001. On completion of his fellowship he joined the Institute of Biomedical Engineering, Imperial College London to work with Professor Tony Cass in the area of Bionanotechnology and Biosensors. Here he developed minimally invasive microneedles, from photolithographic fabrication to high throughput fabrication, taking these microneedles from the lab to the clinic . Sanjiv was involved in a NIHR (i4i) funded research project involving clinical studies in healthy volunteers and participants with T1D with renowned Endocrinologist Clinicians; Professor Desmond Johnston and Professor Nick Oliver. He has published over 50 research articles and has patents filed in Germany, UK and the United States.


Sanjiv is currently a Senior Lecturer in Medical Engineering in the College of Engineering at Swansea University. At Swansea, he is working on therapeutic drug delivery and diagnostic (theranostic) applications of polymeric microneedles.
 

James Birchall

Professor of Pharmaceutical Sciences and Deputy Head of School, Cardiff University
James  Birchall

Mateusz Hasso-Agopsowicz

Technical Officer, World Health Organization
Mateusz Hasso-Agopsowicz

Dr Mateusz Hasso-Agopsowicz is a Technical Officer in the Department of Immunization, Vaccines and Biologicals (IVB) at the World Health Organization (WHO). He holds a PhD in Vaccine Immunology from the London School of Hygiene and Tropical Medicine (LSHTM). Dr Mateusz leads theme areas on the role of vaccines in reducing antimicrobial resistance (AMR), prioritisation of vaccines for research and development, and supporting the development of vaccine-microarray patches (MAPs). MAPs are priority innovation for WHO and together with partners WHO is developing tools and technical products to advance development of MAPs.

Michael Schrader

Co-Founder & CEO, Vaxess Technologies
Michael Schrader

Muhammet Avcil

Managing Director, Imperial BioScience
Muhammet Avcil

Nuria Puigmal Dominguez

Blavatnik Fellow, Harvard Business School
Nuria Puigmal Dominguez

Nuria Puigmal Dominguez

Blavatnik Fellow, Harvard Business School
Nuria Puigmal Dominguez

Pawel Biernat

Chief Technology Officer and Co-Founder, Biotts
Pawel Biernat

Renske Hesselink

CMC Technology Lead, CEPI
Renske Hesselink

Sanjiv Sharma

Senior Lecturer in Medical Engineering, Swansea University
Sanjiv Sharma

Sanjiv Sharma

Senior Lecturer in Medical Engineering, Swansea University
Sanjiv Sharma

Steven Damon

CEO, Micron Biomedical
Steven Damon

Steven Damon

CEO, Micron Biomedical
Steven Damon

Mr. Damon is an industry veteran who has over 30 years of experience with various business roles in the medical device and pharmaceutical industries. He served as the CEO and President of 4P Therapeutics, a company he founded in 2011 and sold to Nutriband Inc. in 2018. He served as Chairman and President of Absorbable Polymers International, a company he founded in 2003 as a wholly owned subsidiary of DURECT corporation. Steve has held Executive positions in Mergers & Acquisitions, Business Development and Commercial Development for several companies including Femasys, Altea Therapeutics, DURECT and Kimberly-Clark Health Care.
In addition to his role with Micron, Steve serves on the Board of Directors for Temple Therapeutics. He is a long-time member of Georgia Bio and serves on its Board of Directors.
 

Thomas Lake

SVP, Vaccine Alliances & Commercialization, Vaxxas Inc
Thomas Lake

Waleed Faisal

Project Manager, University College Cork
Waleed Faisal

sponsors


Business Manager
Biotts
Former Senior Expert Nonclinical Safety
Bayer AG
Chief Executive Officer
Vaxxas
VP
Emergex USA Corporation
Managing Director
Imperial BioScience
Chief Technology Officer
Corium International
Chief Technology Officer and Co-Founder
Biotts
Senior Lecturer in Medical Engineering
Swansea University
Professor of Pharmaceutical Sciences and Deputy Head of School
Cardiff University
Technical Officer
World Health Organization
Co-Founder & CEO
Vaxess Technologies
Managing Director
Imperial BioScience
Blavatnik Fellow
Harvard Business School
Blavatnik Fellow
Harvard Business School
Chief Technology Officer and Co-Founder
Biotts
CMC Technology Lead
CEPI
Senior Lecturer in Medical Engineering
Swansea University
Senior Lecturer in Medical Engineering
Swansea University
CEO
Micron Biomedical
CEO
Micron Biomedical
SVP, Vaccine Alliances & Commercialization
Vaxxas Inc
Project Manager
University College Cork

Gold Sponsor

Sponsors

Official Media Partner

VENUE

Hilton London Kensington

179-199 Holland Park Avenue, London, United Kingdom

At the heart of the Holland Park district, our hotel is 10 minutes from Westfield London shopping center. We're blocks from Shepherd's Bush Underground station, linking to central London, and Kensington Palace and Gardens are two miles from us. Enjoy 24-hour access to our fitness center.

 
Join us in WestEleven for hearty buffet breakfast, a great way to start the day! Our Avenue Bar and Lounge serves light bites throughout the day as well as a delicious, seasonal dining menu.”

A number of our clients have been approached by third party organisations offering to book hotel rooms. We would advise that you do not book through them as they are not representing the SMi Group. SMi Group books all hotel rooms directly. If you are approached by a third party organisation then please contact us before making any bookings. If you have already booked a hotel room using a third party organisation, we would highly recommend contacting the hotel you were booked into to ensure a booking has been made for you. We would also advise you to please check the terms and conditions of the booking carefully.
HOTEL BOOKING FORM

60 seconds with Michael Schrader, Co-Founder & CEO, Vaxess Technologies

Download

Past Presentation - Bayer

Download

Past Presentation: Nutriband

Download

Past Presentation - Starton Therapeutics

Download

Letter from the Chairs

Download

2024 Brochure

Download

Sponsors and Exhibitors


Crux

Gold Sponsor
https://www.cruxproductdesign.com/

Crux was founded to address challenging technical briefs and deliver compelling solutions for the drug delivery and medical device sectors. Based in Bristol, United Kingdom, our technical team champion evidence-based problem solving, coupling world-class equipment, software and facilities with a scientific approach to maximise success. Be it discovering unmet user needs, developing novel products or deploying new technologies, our team are dedicated to solving our client’s biggest problems..


Sponsors


Nemaura Pharma

Sponsors
https://nemaura.co.uk/

Nemaura Pharma was founded in 2005 and specialises in skin drug delivery. The company has a number of drug delivery technologies for topical, transdermal and injectable drug delivery, and an in-house GMP IMP suite as well as ISO13485 accreditation for the design, development and manufacture of medical devices and injectable systems. The company is based in Loughborough, UK.


Media Partners


The Medicine Maker

Official Media Partner
https://themedicinemaker.com/?utm_source=media_partner_24&utm_medium=event&utm_campaign=sae_media_logo

The Medicine Maker is a print and digital publication as well as a weekly newsletter. At The Medicine Maker, we bring people into the limelight, showcasing the industry’s success stories and examining its biggest points of contention. Engaging content covers the entire spectrum of drug development, keeping all medicine makers up to date with the most pressing topics, trends and technologies driving the pharma industry forward. Register for your FREE print or digital magazine or subscribe to our newsletter here! https://themedicinemaker.com/?utm_source=media_partner_24&utm_medium=event&utm_campaign=sae_media_logo

SAVE TO


Outlook Calendar  OUTLOOK CALENDAR
Google Calendar  GOOGLE CALENDAR
ICal Calendar  ICAL CALENDAR
Yahoo! Calendar  YAHOO! CALENDAR

Hilton London Kensington

179-199 Holland Park Avenue
London W11 4UL
United Kingdom

Hilton London Kensington

At the heart of the Holland Park district, our hotel is 10 minutes from Westfield London shopping center. We're blocks from Shepherd's Bush Underground station, linking to central London, and Kensington Palace and Gardens are two miles from us. Enjoy 24-hour access to our fitness center.

 
Join us in WestEleven for hearty buffet breakfast, a great way to start the day! Our Avenue Bar and Lounge serves light bites throughout the day as well as a delicious, seasonal dining menu.”
HOTEL BOOKING FORM

Title

SubTitle
speaker image

Content


Title


Description

Download

Title


Description

Download

Title


Description


Download


WHAT IS CPD?

CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

CPD AND PROFESSIONAL INSTITUTES

There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

GLOBAL CPD

Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

CPD Certificates

We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

Event Title

Headline

Text
Read More

I would like to speak at an event

I would like to attend an event

I would like to sponsor/exhibit at an event

SIGN UP OR LOGIN

Sign up
Forgotten Password?

Contact SAE Media Group

UK Office
Opening Hours: 9.00 - 17.30 (local time)
SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
Website: http://www.smgconferences.com Email: events@saemediagroup.com
Registered in England - SMi Group Ltd trading as SAE Media Group




Forgotten Password

Please enter the email address you registered with. We will email you a new password.

Thank you for visiting our event

If you would like to receive further information about our events, please fill out the information below.

By ticking above you are consenting to receive information by email from SAE Media Group.
Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
Should you wish to update your contact preferences at any time you can contact us at data@smgconferences.com.
Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out

Fill in your details to download the brochure

By submitting this form you agree to our privacy policy and consent to receiving communications, you may opt out at any time.